DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

References

Arnason JE, Luptakova K, Rosenblatt J. et al.
Yttrium-90 ibritumomab tiuxetan followed by rituximab maintenance as treatment for patients with diffuse large B-cell lymphoma are not candidates for autologous stem cell transplant.

Acta Haematol 2015;
133 (04) 347-353

Download Bibliographical Data

Access:
Access: